$700M BNB Move Fails to Save Windtree From Nasdaq Delisting
Windtree Therapeutics, a biotech firm that recently announced a $700 million BNB treasury strategy, has been delisted from Nasdaq for failing to meet a listing requirement. The BNB Inspired Rally…